Keyphrases
Neuroblastoma
58%
Acute Lymphoblastic Leukemia
47%
Ewing Sarcoma
45%
Bone Marrow
43%
Hematopoietic Stem Cell Transplantation
42%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
42%
Chemotherapy
39%
Bone Marrow Transplantation
39%
Israel
39%
Childhood Acute Lymphoblastic Leukemia
38%
Pediatric Patients
36%
Event-free Survival
36%
Marrow Transplantation
36%
Fas Ligand
35%
Transplantation
35%
Israeli
35%
Pediatric
34%
Graft-versus-host Disease (GvHD)
32%
Apoptosis
32%
Tumor
30%
Hematopoietic Stem Cells
29%
Overall Survival
29%
Engraftment
26%
Pediatric Hematology
23%
Allogeneic Bone Marrow Transplantation
22%
European Society
22%
Stem Cell Transplantation
22%
Working Diagnosis
21%
Pediatric Diseases
21%
T Cells
20%
Acute Myeloid Leukemia
19%
Congenital Dyserythropoietic Anemia
19%
Anemia Type
19%
Hematopoietic Cells
19%
Survivors
18%
Bone Marrow Cells
18%
Working Party
18%
Risk Factors
18%
Quantitative PCR
17%
Pediatric Hematopoietic Stem Cell Transplantation
17%
Leukemia
16%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
16%
Ewing Sarcoma Family of Tumors
15%
Fertility Preservation
15%
High Dose
15%
Fanconi Anemia
15%
Pediatric Oncology
15%
NOD Mice
14%
Peripheral Blood Stem Cell Collection
14%
Immunomodulation
14%
Medicine and Dentistry
Disease
100%
Pediatrics
78%
Acute Lymphoblastic Leukemia
62%
Hematopoietic Stem Cell Transplantation
54%
Neoplasm
54%
Ganglioneuroblastoma
38%
Malignant Neoplasm
37%
Pediatrics Patient
35%
Bone Marrow Transplantation
33%
Transplantation
32%
Childhood Cancer
32%
Overall Survival
32%
Ewing Sarcoma
32%
Event Free Survival
28%
Engraftment
28%
Oncology
27%
Leukemia
27%
Stem Cell
26%
Adolescent
25%
Graft Versus Host Reaction
23%
Infection
23%
T Cell
23%
Acute Myeloid Leukemia
23%
Hematopoietic Stem Cell
23%
Conditioning
22%
Pediatric Hematology
22%
Allogeneic Hematopoietic Stem Cell Transplantation
19%
Drug Megadose
19%
Central Venous Catheter
18%
Pediatric Disease
17%
Programmed Cell Death
17%
Stem Cell Therapy
16%
Fas Ligand
15%
Peripheral Blood Stem Cell
15%
Supportive Care
15%
Fertility Preservation
15%
Cord Blood
15%
Cord Blood Stem Cell Transplantation
14%
Endocrine Disease
13%
Minimal Residual Disease
13%
Methotrexate
13%
In Vitro
13%
Sickle-Cell Disease
12%
Cancer
12%
Matched Donor
12%
B Cell
11%
Recurrent Disease
11%
Tumor Cell
11%
High Dose Chemotherapy
11%
Brain Tumor
11%